Ignite Creation Date:
2025-12-24 @ 4:54 PM
Ignite Modification Date:
2026-01-02 @ 10:56 AM
Study NCT ID:
NCT00414050
Status:
COMPLETED
Last Update Posted:
2017-05-23
First Post:
2006-12-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of 2 Doses of a Hepatitis B Vaccine (V232 RECOMBIVAX HB) in Healthy Infants (V232-057)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-10-06
Start Date Type:
ACTUAL
Primary Completion Date:
2007-10-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-10-24
Completion Date Type:
ACTUAL
First Submit Date:
2006-12-20
First Submit QC Date:
None
Study First Post Date:
2006-12-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2008-10-15
Results First Submit QC Date:
None
Results First Post Date:
2009-04-14
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-12
Last Update Post Date:
2017-05-23
Last Update Post Date Type:
ACTUAL